Thank you, Mr. Chair.
Thank you to the witnesses for joining us here again today.
I want to address Dr. Khan and some of the comments you made. In particular, I am hoping to get a grasp on when BlueDot—obviously ahead of the curve, early on—provided the first data regarding the coronavirus to the Public Health Agency of Canada.